PharmaPlus Consultancy

What PharmaPlus Consultancy does

PharmaPlus Consultancy BV is a Dutch private limited company headquartered in Huizen, The Netherlands, providing specialized advisory services for pre-commercial stage biopharmaceutical in-licensing and out-licensing transactions. The firm operates globally on a regional or worldwide basis and is led by founder and principal Karin Bakker, a pharmacist with more than 25 years of experience in business development, technology scouting, and licensing deal benchmarking across modalities including antibodies, cell therapy, drug conjugates, peptides, and small molecules.

The company delivers three core services: In-Licensing Services (technology scouting and identification of compounds, products, and technologies from companies, incubators, startups, research institutes, government institutes, and individual investigators based on client confidential briefs), Out-Licensing Services (identification of business partners, conference representation, introduction coordination, and support through term sheet and definitive agreement negotiations), and Asset Commercialization Check (a fixed-fee analysis of therapeutic inventions covering non-confidential slide decks and patent situations, delivered as a two-page anonymous feedback report). The underlying capability rests on a proprietary in-house partnering database combined with external databases, partnering conference participation, and direct contacts at technology transfer offices in more than 1,600 medical non-profit research organizations worldwide.

The business model is professional services only. Pricing is not publicly disclosed but combines fixed fees (Asset Commercialization Check, In-Licensing scouting), retainer and/or success fees (Out-Licensing engagements), and pay-per-meeting fees for conference representation. Clients span startups, SMEs, mid-sized and large pharmaceutical companies, research institutes, technology transfer organizations, and law firms, with all client engagements held under strict confidentiality. The firm has no external institutional investors, operates without a public listing, and is founder-owned and operated.

Name

PharmaPlus Consultancy

Legal name

PharmaPlus Consultancy BV

Website

https://pharmaplus.nl

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

PharmaPlus Consultancy BV is a Dutch founder-led boutique advising pre-commercial biopharmaceutical companies on global in-licensing, out-licensing, and asset commercialization, leveraging a proprietary partnering database and 1,600+ research organization contacts.

Ownership category

akta.pro rank

Product category

Pharmaceutical Licensing Advisory

NAICS

Management Consulting Services (54161)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Payer & HTA Engagement (Reimbursement/Submissions) (HLAIAKAD)

akta.pro secondary industry

Patient Access Programs & Affordability (Copay/Hubs/PSP) (HLAIAKAG)

Keywords

• Biopharmaceutical licensing advisory
• In-licensing scouting services
• Out-licensing partner identification
• Asset commercialization analysis
• Technology transfer consulting

Headquarters

HQ city

Huizen

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Technology or R&D, Infrastructure

Revenue model

1. Asset Commercialization Check Services: Fixed fee service for quick asset commercialization check on therapeutic inventions. Includes analysis of non-confidential slide deck and patent situation, with a two-page report providing anonymous feedback from approached companies.
2. Out-Licensing Partnering Services: Retainer and/or success fee structure for identifying business partners, representing clients at partnering conferences, coordinating introductions, supporting negotiations, and ensuring deal closure.
3. In-Licensing Services: Fixed fee service for identifying and scouting in-licensing opportunities from companies, incubators, startups, research institutes, government institutes, and individual investigators based on client confidential brief.

Pricing tiers

Go-to-market motion3 records

Distribution channels2 records

Marketing channels3 records

Core offering

PharmaPlus Consultancy is a boutique advisory firm that supports pre-commercial stage biopharmaceutical licensing transactions from sourcing through closing. It offers three services: In-Licensing Services (identifying and scouting licensing opportunities from companies, startups, research institutes, and individual investigators), Out-Licensing Services (identifying and connecting clients to regional or global partners, conference representation, and negotiation support), and Asset Commercialization Check (analyzing therapeutic inventions and patent situations to deliver anonymous market feedback). Engagements are delivered globally on a fixed fee, retainer, and/or success fee basis.

Product overview

PharmaPlus Consultancy offers a suite of three consulting services focused on pre-commercial stage biopharmaceutical licensing transactions. The core offerings are In-Licensing Services (identifying and scouting licensing opportunities from companies, startups, research institutes, and individual investigators), Out-Licensing Services (identifying business partners and supporting deal-making through the entire transaction process), and Asset Commercialization Check (analyzing therapeutic inventions and patent situations to identify partnering hurdles). All services leverage the company's proprietary in-house partnering database, external databases, conferences, and global corporate network to operate on a regional or worldwide basis.

Differentiator

Problem solved

Functional benefit

Products and services

• In-Licensing Services Identifies and scouts small and large biopharmaceutical companies, incubators, startups, research institutes, government institutes, and individual investigators for in-licensing opportunities including new compounds, products, and technologies in requested development stages and disease areas on a regional or worldwide basis. Targets companies seeking to fill pipeline gaps through licensing.
• Out-Licensing Services Identifies and connects clients with the best matching business partners for out-licensing opportunities, represents clients at partnering conferences, coordinates introductions, and supports term sheet and definitive agreement negotiations through deal closure. Designed for SME and startup companies seeking global or regional partners for their biopharmaceutical assets and technology.
• Asset Commercialization Check Provides a quick analysis of therapeutic inventions for innovators, research institutes, startups, companies, and law firms. Analyzes non-confidential slide decks and patent situations, approaches companies worldwide to check interest, and delivers anonymous feedback in a two-page report to identify potential partnering hurdles.

Quantifiable outcome

• Advised European technology transfer organization to not invest further in 23% of problematic patent applications, and to invest in research and/or adapt partnering strategy for remaining 77%
• +6 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators4 records

Recent moves1 record

Expansion highlights4 records

Broad incumbents

• ZS Associates: Global consulting and technology firm with a deep life sciences practice covering strategy, commercial, and BD advisory. Comparable client base of large pharma companies but broader service portfolio than PharmaPlus.
• McKinsey & Company (Pharma & Medical Products Practice): Global consulting giant with a dedicated pharma and medical products practice covering BD, licensing, and corporate strategy. Competes for the same enterprise pharma clients as PharmaPlus but offers full-spectrum advisory beyond licensing.
• L.E.K. Consulting: Global management consulting firm with a sizable life sciences practice advising pharma and biotech on strategy, licensing, and M&A. Overlaps with PharmaPlus in licensing advisory but operates at much larger scale and across broader commercial questions.

Direct peers

• Locust Walk: Global life sciences transaction advisory firm focused on biopharma partnering, licensing, and M&A. Closely comparable in its end-to-end support of out-licensing and in-licensing transactions across modalities and geographies.
• Alacrita Consulting: UK-based pharma and biotech consulting firm offering licensing advisory, due diligence, and strategic consulting to pharma and biotech clients — closely aligned with PharmaPlus's boutique advisory model.
• Health Advances: Biopharma strategy and transaction advisory firm supporting licensing, M&A, and commercial strategy for pharma and biotech — comparable to PharmaPlus in transaction-focused advisory for pre-commercial assets.
• Defined Health: US-based biopharma business development advisory firm that helps biotech and pharma clients identify in-licensing opportunities, structure deals, and secure partners — directly comparable to PharmaPlus's pre-commercial licensing services.
• Catenion: Biopharma strategy consulting firm supporting R&D and business development decisions for pharma and biotech clients, with comparable pre-commercial strategic advisory offerings.
• Back Bay Life Science Advisors: US-based life sciences advisory firm supporting biopharma clients with strategy, financing, and business development — overlapping with PharmaPlus on pre-commercial BD and partnering advisory.

Regional players

• Smart Pharma Consulting: French-based pharma consulting firm specializing in strategy and business development for pharmaceutical companies — comparable boutique advisory positioning to PharmaPlus but primarily serving European clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PharmaPlus Consultancy